Ballentine Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.45M	Buy	104,888 +435	+0.4%	+$6.06K	0.02%	268
2025 Q4	$1.47M	Sell	104,453 -27,709	-21%	-$389K	0.02%	247
2025 Q3	$1.85M	Sell	132,162 -13,056	-9%	-$188K	0.03%	207
2025 Q2	$2.18M	Buy	145,218 +70,110	+93%	+$1M	0.03%	179
2025 Q1	$991K	Sell	75,108 -29,607	-28%	-$409K	0.02%	295
2024 Q4	$1.65M	Buy	104,715 +27,455	+36%	+$412K	0.03%	208
2024 Q3	$1.23M	Buy	77,260 +11,195	+17%	+$180K	0.02%	245
2024 Q2	$1.01M	Sell	66,065 -890	-1%	-$12.8K	0.02%	261
2024 Q1	$982K	Buy	66,955 +13,330	+25%	+$195K	0.02%	256
2023 Q4	$746K	Buy	53,625 +19,500	+57%	+$261K	0.02%	280
2023 Q3	$456K	Buy	34,125 +1,875	+6%	+$25.4K	0.01%	339
2023 Q2	$407K	Buy	+32,250	New	+$376K	0.01%	366